Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Tetsutaro Hayashi
Based on 10 articles published since 2008
||||
Expertise Level
The expertise of Tetsutaro Hayashi ranks in the Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    Hiroshima University      
2017
  • Department of Urology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Center and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Thoracic Oncology and Cancer Biology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii. · Department of Molecular Pathology, Graduate School of Biochemical and Health Sciences, Hiroshima University, Hiroshima, Japan. · Department of Pathology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan. · Department of Urology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan. · Pubmed 28734027
  • Department of Urology, University of Bern, Bern, Switzerland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Department of Urology, University Hospital of Southampton, Hampshire SO16 6YD, UK. · Institute of Pathology, University of Bern, Bern, Switzerland. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada. · Pubmed 28205537
2016
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26769750
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
2011
  • Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Japan. · Pubmed 22014052
2009
  • Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8551, Japan. · Pubmed 19082448
Probable:    University of British Columbia      
2016
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26769750
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Johannes Gutenberg University, Mainz, Germany. · Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, BC, Canada. · Research and Development, GenomeDx Biosciences, Vancouver, BC, Canada. · Pubmed 26041878
2014
  • Department of Urologic Sciences, University of British Columbia. · Department of Urologic Sciences, University of British Columbia; · Pubmed 24561487
2013
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 23555699
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23500642
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Tetsutaro Hayashi in 2008-2019 about Urinary Bladder Neoplasms:

  • Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer. 2017
  • Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy. 2017
  • Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy. 2016
  • Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer. 2015
  • Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. 2015
  • Minimally invasive establishment of murine orthotopic bladder xenografts. 2014
  • Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach. 2013
  • Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa. 2013
  • Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma. 2011
  • Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker. 2009
Show List of Full Article Records
Google Searches

Learn more about Tetsutaro Hayashi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Hiroshima University
University of British Columbia
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Hiroshima University
2017
  • Department of Urology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Center and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Thoracic Oncology and Cancer Biology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii. · Department of Molecular Pathology, Graduate School of Biochemical and Health Sciences, Hiroshima University, Hiroshima, Japan. · Department of Pathology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan. · Department of Urology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan. · Pubmed 28734027
  • Department of Urology, University of Bern, Bern, Switzerland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Department of Urology, University Hospital of Southampton, Hampshire SO16 6YD, UK. · Institute of Pathology, University of Bern, Bern, Switzerland. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada. · Pubmed 28205537
2016
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26769750
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
2011
  • Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Japan. · Pubmed 22014052
2009
  • Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8551, Japan. · Pubmed 19082448
University of British Columbia
2016
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26769750
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Johannes Gutenberg University, Mainz, Germany. · Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, BC, Canada. · Research and Development, GenomeDx Biosciences, Vancouver, BC, Canada. · Pubmed 26041878
2014
  • Department of Urologic Sciences, University of British Columbia. · Department of Urologic Sciences, University of British Columbia; · Pubmed 24561487
2013
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 23555699
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23500642
Yearly article counts 002121201010
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.